Your browser doesn't support javascript.
loading
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.
Riccio, Anna Maria; Mauri, Pierluigi; De Ferrari, Laura; Rossi, Rossana; Di Silvestre, Dario; Benazzi, Louise; Chiappori, Alessandra; Dal Negro, Roberto Walter; Micheletto, Claudio; Canonica, Giorgio Walter.
Affiliation
  • Riccio AM; Respiratory Diseases and Allergy Unit, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.
  • Mauri P; Proteomics and Metabolomics Unit, Institute for Biomedical Technologies, CNR, Milan, Italy.
  • De Ferrari L; Respiratory Diseases and Allergy Unit, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.
  • Rossi R; Proteomics and Metabolomics Unit, Institute for Biomedical Technologies, CNR, Milan, Italy.
  • Di Silvestre D; Proteomics and Metabolomics Unit, Institute for Biomedical Technologies, CNR, Milan, Italy.
  • Benazzi L; Proteomics and Metabolomics Unit, Institute for Biomedical Technologies, CNR, Milan, Italy.
  • Chiappori A; Respiratory Diseases and Allergy Unit, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.
  • Dal Negro RW; National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, CESFAR, Verona, Italy.
  • Micheletto C; Respiratory Unit, Mater Salutis Hospital, Legnago, Verona Italy.
  • Canonica GW; Respiratory Diseases and Allergy Unit, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.
Clin Transl Allergy ; 7: 6, 2017.
Article in En | MEDLINE | ID: mdl-28293414

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Transl Allergy Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Transl Allergy Year: 2017 Document type: Article